Matthew R. Silver

Davis Polk advised NatWest Markets Plc, a public limited company incorporated under the laws of Scotland, in connection with the update of its $10 billion 144A medium-term notes programme…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $750 million of its 2.250% senior notes due 2030. MMC will use the net proceeds…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of $1 billion aggregate principal amount of its 2.050% senior notes due 2022, $750 million…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.3 billion of senior notes. The offering consisted of two tranches of senior notes,…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of its 3.625% senior notes due 2030. The notes are guaranteed by…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. Based in…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of €500 million aggregate principal amount of its 0.250% senior notes due 2028 (the “2028 notes”)…

Davis Polk advised Cogna Educação S.A. in connection with its equity offering of 232,358,004 common shares for an aggregate amount of approximately R$2.6 billion (approximately $600 million…

Davis Polk advised Afya Limited on its SEC-registered follow-on offering of an aggregate of 12,426,740 Class A common shares, of which 3,019,928 shares were issued and sold by Afya and…

Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…